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Blood Coagulation in Uremic Patients 
Before and After Hernodialysis 
and Transplantation of the Kidney 
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T. L. MARCHIORO, MD; AND T. E. STARZL, MD, DENVER 
ALTHOUGH the bleeding tendency of 
patients with renal failure is well known, the 
literature concerning the cause of the coag- 
ulation failure is both meager and confusing. 
The hemostatic abnormality has been said to 
be greater in acute than in chronic uremia, 
and even to occur by a different mecha- 
n i ~ m . ~ l  A variety of clotting defects have 
been described in both types of patients. 
Various plasma clotting factors have been 
found to be moderately reduced lo with in- 
constant hypofibrinogenemia,*-lo with or 
without involvement of the prothrombin 
~ o m p l e x . ~ . ~  Abnormal thrombelastograms, 
reduced heparin t o l e r a n ~ e , ~  and prolonged 
thrombin time lo have also been seen in 
many, but not all, patients. 
The most consistently reported coagula- 
tion abnormality of uremia has been a de- 
ficiency in prothrombin c o n s u ~ n p t i o n . ~ , ~ , ~ ~ *  
21 ,22  In some cases, this could be explained 
solely by the thrombocytopenia which has 
been thought by some to be a common 9f21 
and by others to be a rare complication 
of azotemia. I n  a significant number of 
patients, however, poor prothrombin con- 
sumption and other abnormalities of platelet 
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function have occurred in the absence of 
thrombocytopenia. Cahalone et a1 believed 
that there was inhibition or destruction of 
platelet factor-3 activity in the uremic plasma 
of such patients with the consequent loss of 
platelet thromboplastic function. In a subse- 
quent report the presence of any platelet 
abnormality was denied.l 
In previous times, precise Itnowledge of 
clotting in the terminally uremic patient was 
of limited practical use since death was fre- 
quently imminent and unpreventable. With 
the developlnent of renal dialysis and homo- 
transplantation, the outlook is no longer 
hopeless and the avoidance and control of 
hemorrhage has assumed increased impor- 
tance. In  this report an attempt will be made 
to characterize the coagulation abnormalities 
of uremia, to enumerate the screening tests 
used for detection of potential bleeders, to 
evaluate the methods available for correction 
of the clotting defects, and to describe some 
effects of hemodialysis and renal homotrans- 
plantation upon coagulation. 
Methods 
Most of the uremic ratients studied llatl bee11 
admitted to the hospital for hemodialysis; many 
ultimately became candidates for renal homotrans- 
plantation. The studies obtained at admission were 
considered as controls against which to judge the 
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effect of subsequent therapy or  of progression of 
disease. The following tests were performed: 
throtnbin generation,'' recalcification time, and 
prothrombin consumption measured as serum pro- 
thrombin time? prothrombin complex measured as 
prothrombin time with the use of human brain 
tllromboplastin,l5 thrombelastograms,l? thrombin 
time? and euglobulin lysis time." Blood platelets 
were usually counted with the phase  microscope^ 
or, alternatively, estimated upon smear. Blood for 
all examinations was obtained with the two 
syringe technique using siliconized equipment and 
using citrate as anticoagulant (four parts blood to 
one part 3.8% sodium citrate). Centrifugatiou for 
separation of plasma was carried out in siliconized 
tubes at 1,470 g for five ~ninutes;  with this pro- 
cedure all the platelets remained in the supci-natant 
plasma. 
The thrombin generation test reflects the con- 
version of prothrombin to thrombin, a reaction 
which depends upon the activity of intrinsic blood 
thromboplastin. Freshly drawn plasma is recalcified 
Fig  1 .-Thrombin gen- 
eration pattern in uremic 
patients before and after 
homotransplantation of 
kidney. (Shrrded Area) 
Range of value from 25 
health individuals. (Black 
curve? Average thrombin 
generation values of 34 
uremic patients indicating 
eficient thrombin genera- 
tion. (Dotted Curve) 
Average thrombin gen- 
eration values of 14 
patients one to ten 
days after transplantation 
showing normalization. 
(Dashed Curve) Aver- 
age thrombin generation 
values of 11 ~a t i en t s  10 
to 75 days aiter trans- 
plantation of the kidney, 
indicating hypercoagula- 
hility. 
and incubated and an aliquot added every four 
minutes to a standard fibrinogen solution. The 
clotting time of the fibrinogen solution is thus a 
ineasure of the speed and coinpleteness of thrombin 
formation and ultimately for the amount of active 
thrombin remaining in the serum; the serial de- 
terminations provide data for graphs (Fig  1, 2, 
3)  which depict plasma incubation time (abscissa) 
and fibrinogen clotting time (ordinate). 
Plasma was used for substitution tests in two 
ways. First, blood was drawn from a healthy donor 
and centrifuged a t  1,470 g for five minutes. All 
platelets remained in the supernatant; this "fresh 
plasma" was used within 30 minutes. Secondly, the 
above preparation was converted to "fresh frozen 
platelet-rich plasma" by first freezing (a t  -20 C) 
and then thawing. I t  was found that about half .the 
platelets were destroyed by freezing and then thaw- 
ing, thereby releasing platelet clotting factors ; such 
plasma was used both for in vitro testing and for 
administration to patients. In  both kinds of plasma, 
the original number of platelets was greater than 
Fig 2.-Effect of he- 
modialysis upon thrombin 
generation in patient 9 
(chronic glomerulonephri- 
tis). Oct 20: before 
dialysis. Activity of pro- 
thrombin complex 45%, 
platelets 163,000, BUN 
316 mgJlOO cc. Oct 22: 
after two dialyses. Plate- 
lets 91,250; BUN 263 
mgJl0O cc 10-23: BUN 
160 mgJlOO cc. Thrombin 
generation starts a t  nor- 
mal time after third 
hemodialysis ; yield, how- 
ever, remains deficicnt. 
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2-27 1 Fig 3.-Trend of throm- 
I bin generation pattern 
1 a before and after homo- 
I ' transplantation of kidney 
I 4- 8 1 (chronic glomerulonephri- 
I I tis). Patient 15. Curve, 
I Feb 12: five days before 
I transplantation. Platelets 244,000; BUN 174 mg/ 
100 cc. Curve, Feb 18: 
2-1 2 one day after homo- C___--- - . . - - -____ 
-, -, transplantation. Marked / improvement. Platelets 285,000; BUN 43 mgJ 
--- / 100 cc. Curve, Feb 27: 
hypercoagulability. Plate- 
lets 581,000; BUN 29 
mgJlOO cc. Curve, April 
8 :  normal pattern. Plate- 
2 0 2 4  MINI lets not done; BUN 22 
I N C U B A T I O N  1 mgJlOO cc. 
I 
in conventional blood bank preparations since the of 40% (range 17% to 64%). None of 41 
speed of centrifugation was less than that custo- patients tested had reduced euglobulin lysis 
marily used. times; on the contrary, the values tended to 
In vitro replacement therapy was also carried 
out with the human brain lipid prepared according be longer than normal. 
to Bell and Alton; using a 1 :I00 dilution with With progression uremia, further 
buffered saline at pH 7.4. Serum ~rothrombin deterioration of all the above clotting param- 
times were measured before and after the addition eters was observed. Serial thrombelasto- 
of the brain lipid. grams showed a progressive delay in the 
beginning and progression of the clot forma- 
Results tion. Most severely affected were thrombin 
Untreated Uremic Patients.-Studies per- generation and the prothrombin complex. 
formed shortly after admissiorl revealed Thrombocytopenia of one fourth or less the 
various clotting defects. Thrombin genera- normal value was seen. Even in such terminal 
tion after 12 and 16 minutes incubation was patients, there was no increase in fibrinolytic 
abnormal in 82%, or 30 of 34 patients (Fig activity. 
1 ) .  In  22 of 26 cases (85%), the thrombin I n  Vitro Correction of the Clotting Ab- 
time was prolonged. Serum prothrombin normalities.-Since deficient thrombin gen- 
time was short (below 30 seconds) in 14 of eration, abnormal prothrombin consumption 
24 (58%). In 16 of 33 patients, {he number (shortened serum prothrombin time), or both 
of platelets was reduced to one half to two were the most common and most serious 
thirds normal. The prothrombin complex clotting defects, attempts were made to re- 
(Quick one-stage prothrombin time) was store normal coagulation in the test tube by 
reduced in 15 of 15 patients to an average the addition of reagents. In  this way, infor- 
TABLE 1.-Serum Prothrombin Time (Seconds) in Uremic Plasma Before and After 
Addition o f  Fresh Plasma, Fresh-Frozen Plasma, or Brain L ipd  (Normal Valzces: 
Above 35 Seconds) 
Without Plus 10 % Plus 5 % Plus 5 % 
Patient Diagnosis Addition Fresh Plasma Fresh-Frozen Plasma Brain Lipid Platelets 
1 Polycystic kidney 25.7 28.7 67.8 43.7 179,000 
2 Acute anuria (postsurgical) 26.8 32.3 * 61.9 94.5 125,000 
3 Chronic glomerulonephritis 22.6 50.6 61.5 145.0 127,000 
4 Chronic bilateral pyelonephritis 29.6 28.8 * 86.3 168.6 162,000 
5 Chronic glomerulonephritis 20.7 31.1 59.7 91.4 92,000 
6 Chronic glomerulonephritis 22.2 28.2 * 49.7 56.5 300,000 
7 Chronic glomerulonephritis 29.2 58.5 108.0 52.0 112,000 
* Only partial correction on addition of 50 % fresh plasma. 
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TABLE 2.-Serum Pr~thromb~in Time, Thrombin Time, and Thrombin Generation 
Before and After Henwdialysk * 
Serum Prothrombin Time Thrombin Time 
. Thrombin Generation 
Patient Diagnosis Before (. . .) Days After Before After After Dialysis 
3 Chronic glomerulonephritis 22.6 1 25.0 33.6 30.7 Improved 
8 Chronic glomerulonephritis 26.3 1 44.0 25 2 2 3 2  Not improved 
9 Chronic glomerulonephritis 35.2 1 44.2 33.0 25.0 Improved 
6 Chronic glomerulonephritis 22.3 1 48.0 28.0 23.0 Improved 
1 Polycystic kidney 29.1 4 29.8 18.8 16.8 Slightly improved 
10 Chronic pyelonephritis 19.8 5 44.6 17.3 17.0 Not done 
- - - 
* Thrombin generation tests were carried out in the blood samples drawn for serum prothrombin time. 
mation was sought which could be applied 
fo r  the planning of corrective systemic 
therapy. 
The deficient prothrombin consumption 
was restored by the addition of brain lipid 
(Table 1) both in the samples containing 
normal platelets or in those with mild throm- 
bocytopenia. Since brain lipid has similar 
clotting properties to those of platelet 
factor-3, this finding was compatible with the 
hypothesis that the deficient prothrombin 
consumption was due to platelet dysfunction 
and led to further studies with replacement 
of platelet factors. First, fresh plasma was 
added to the patient's uremic plasma. Al- 
though improvement in prothrombin con- 
sumption occurred in some cases, there was 
no correction by fresh plasma in others 
(Table 1) at the standard 10% aliquot and 
sometimes even when up to 50% was added. 
The latter observation suggests that uremic 
plasma may exert an inhibitory influence on 
the prothrombin consumption of normal 
plasma. 
In contrast, the addition of 5% fresh- 
frozen platelet-rich plasma obtained from 
the same donor restored prothrombin con- 
sumption in every case (Table 1). These 
findings support the possibility that the 
platelets, which are destroyed by freezing 
and thawing, release platelet factor-3 (or 
some other involved component) which in 
turn binds some substance in uremic plasma 
which inhibits thrombocyte function. 
I n  Viuo Correction of the Clotting Ab- 
normalities.-In several patients, a clinically 
obvious bleeding diathesis seemed to be im- 
proved with infusion of 750 ml fresh-frozen 
platelet-rich plasma. In  one patient with 
diffuse mucosal hemorrhage 750 ml fresh- 
frozen platelet-rich plasma was given con- 
comitantly with a fractionated intravenous 
dose of 50 mg phytonadine. The bleeding 
stopped abruptly. Prothrombin complex rose 
from 7% to 45% and there was improve- 
ment of the thrombelastogram and thrombin 
generation for the ensuing two weeks. 
Effect of Hernodialysis on Clotting Ab- 
nonna1ities.-Six patients were studied. 
Five had poor prothrombin consumption and 
reduced thrombin generation; the sixth had 
deficient thrombin generation alone. After 
hemodialysis, all six patients had some im- 
provement of prothrombin consumption, as 
indicated by subsequent prolongation of the 
serum prothrombin time (Table 2). Thrombin 
generation was also improved (Fig 2)  in 
four of the five cases in which it was de- 
termined (Table 2 ) .  In  all cases there was 
TABLE 3.-Serum Prothrombin Time Before and After Homotranspbantation of the 
Kidney (Normal Values: Above 35 Seconds) 
Serum Prothrombin Time 
Patient Diagnosis Before (. . .) Days After Platelets Before Platelets After 
11 Chronic glomerulonephritis 24.7 3 67.0 Average 201,000 
12 Chronic glomerulonephritis 19.0 17 69.0 100,OMI 209,000 
13 Chronic glomerulonephritis 27.4 60 71.8 217,000 466,000 
14 Chronic glomerulonephritis 20.2 130 77.4 163,000 average 
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TABLE 4.-Thrombin Time (Seconds) Before and After Homotransplantation of 





Transplantatio~l 1-5 Days 1 Month 
some shortening of the thrombin time (Table 
2) after hemodialysis. 
The InBuence of Homotransplantation.- 
Clot formation improved in each of 14 
patients who received a well-functioning 
renal homograft. Serum prothrombin times 
rapidly returned to normal (Table 3). In  
six of six patients the thrombin times were 
shortened and eventually normalized (Table 
4). Serial thrombelastograms showed marked 
improvement of the timing and development 
of the clot, often within a day or two (Fig 
4 ) .  Thrombin generation was equally im- 
proved in each of 14 patients (Fig 1) .  The 
correction was essentially complr.te by the 
first to tenth posttransplant day. Moreover, 
the acute increase in thrombin generation 
actually exceeded the normal pattern in most 
instances inasmuch as it started too early, 
provided a premature maximum yield, or 
both (Fig 1); the resultant hypercoagula- 
bility was in general greatest from 10 to 
17 days after operation. 
The effects of restoration of renal furic- 
Fig 4.-Thrombelasto- 
grams before and after 
homotransplantation of 
kidney (chronic glomeru- 
lonephritis. (Patient 20 : 
thrombelastogram on Oct 
14, four days before 
transplantation, platelets 
62,000, BUN 148 mgJ 
100 cc. Thrombelasto- 
gram on Oct 21, three 
days after transplanta- 
tion, platelets 95,000, 
BUN 20 mgJl00 cc. This 
thrombelastogram is nor- 
mal. Center strip of the 
presurgical thrombelasto- 
gram indicating severe 
platelet insufficiency has 
disappeared and fibrin 
formation starts at nor- 
mal time. 
tion are even more evident in the study of 
individual cases such as that depicted in Fig 
4 and 5. In  these patients the typical defi- 
ciency of thrombin generation existed before 
operation. Within one to three days after 
transplantation, this was dramatically re- 
stored toward normal; there had been essen- 
tially no change in the platelet count. In  the 
patient shown in Fig 4, there was slight 
hypercoagulability after nine days of gootl 
homograft function, but by the seventh 
postoperative week, the pattern was normal. 
In  those patients who achieved long-term 
survival, the correction of the clotting ab- 
normalities was parallel to the quality of 
homograft function. However, when rejec- 
tion occurred, the coagulation defects re- 
verted to the typical uremic pattern. 
All patients who received a successful 
homotransplantation had a marked rise of 
antithroinbin I11 activity.lVn no case has 
this returned to normal, even after observa- 
tion for more than two years. The details 
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and possible significance of this observation 
will be reported separately. 
Comment 
The foregoing data suggest that the spe- 
cific coagulation deficiencies in uremia are 
essentially due to platelet disorders; the ab- 
normal serum prothrombin times and the 
retarded thrombin generation are explicable 
on this basis since in vitro correction is 
possible by addition of material with platelet 
factor-3 function. The poor clotting is ap- 
parently not due primarily to a reduction 
in the number of platelets, since significant 
thrombocytopenia was a relatively uncommon 
finding except in terminal cases. Further- 
more, in vitro correction was accomplished 
less effectively with fresh plasma with its 
normal platelet count than with fresh-frozen 
plasma or brain lipid which either contained 
a reduced number of platelets or none at  
all, respectively. 
Instead, the findings in the present study 
support the contention of Cahalone et a1 
who believed that some substance was pres- 
ent in uremic plasma which inhibited platelet 
function; they demonstrated that such plasma 
abolished the coagulating function of normal 
platelets within 1s hours. Inasmuch as the 
clotting abnormality may be improved by 
hemodialysis it might be contended that the 
hypothetical material can cross the membrane 
of the artificial kidney, although such an in- 
terpretation is highly speculative since the 
homologous blood used to prime the extra- 
corporeal circuit may theoretically have con- 
tributed. The beneficial effect of agents such 
as fresh-f rozen platelet-rich plasma and brain 
lipid raise the possibility that platelet fac- 
tor-3 may bind with and inactivate the 
inhibitory factor. 
Other changes in coagulation were minor 
and probably relatively nonspecific. Pro- 
longed thrombin times similar to those in 
the present report have been seen in patients 
with heart diseasel5pZ0 and other chronic 
illnesses. The moderate reduction in pro- 
thrombin complex (factors 11, V, VII, X )  
reported in the present study is probably due 
at least in part to the liver disease which 
often accompanies uremia.* That the hepatic 
injury was not severe is indicated by the 
facts that plasma fibrinogen tended to be 
higher than normal and that there was no 
increased fibrinolytic activity. 
The retarded thrombin generation could 
be easily restored to normal in the test tube, 
but the effects of systemic therapy or renal 
hemodialysis were far less predictable. Al- 
though examples of apparent improvenlent 
of this test were seen both with infusion of 
fresh-frozen platelet-rich plasma (in com- 
bination with phytonadine), or with hemo- 
dialysis, the correction was at best partial 
and transient. In contrast, successful homo- 
transplantation restored effective coagulation 
rapidly, for as long as adequate renal func-  
tion was maintained, and without fail. A11 
F i g  5 . - T r e n d  o f  
thrombin generation pat- 
tern before and after 
homotransplantation of 
kidney (chronic glomeru- 
lonephritis) . Patient 11. 
Curve, April 30: very 
deficient thrombin genera- 
tion. Adequate platelets 
on smear; BUN 230 mg/ 
100 cc. Curve, May 
6: three days after 
transplantation. Marked 
improvement. Platelets 
201,000; BUN 25 mg/ 
100 cc Curve, May 23: 
no change. Platelets 569,- 
000 ; BUN 37 mgJlOO cc. 
Curve, June 5 : further 
improvement but not com- 
pletely normal thrombin 
generation. Platelets 553,- 
000; BUN 46 mgJlOO cc. 
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improvement, if not a complete correction, 
was often present within 24 hours. Con- 
ceivably, some of the immediate alterations 
could have been attributable to the non- 
specific effects of surgery, to blood trans- 
fusions used at this time, to the splenectomy 
which was also performed in all of these 
patients,ll or to the administration of corti- 
costeroids in many cases. Nevertheless, the 
principal benefit was clearly the consequence 
of reestablishment of adequate renal excre- 
tion. I t  deteriorated only with the return 
of renal failure. Control studies performed 
prior to transplantation indicated that aza- 
thioprine was without influence on the re- 
sults of the coagulation studies. 
In  actuality, the intensity of clotting not 
only reached, but exceeded, normal values 
during the first few weeks, rendering the 
patients hypercoagulable from a laboratory 
point of view. Whether the clegree of 
hypercoagulability is unique in renal homo- 
transplantation, is the consequence of 
immunosuppressive drugs other than aza- 
thioprine, splenectomy, or both, or is only an 
exaggeration of the well-known increased 
tendency to accelerated clotting after any 
operation cannot be answered with certainty. 
It is, however, worth noting that the in- 
cidence of pulmonary embolization in cases 
of homotransplantation has been materially 
greater than in the average postoperative pa- 
tient.ll 
In the course of this study, a battery of 
examinations was carried out not only in 
order to characterize the abnormalities of 
clotting which might be present, but also to 
define which tests would have the greatest 
practicality for the study and management 
of future cases. In  view of the findings 
herein reported, it is thought that the ideal 
analysis should be sensitive for platelet 
function and endogenous inhibitors, should 
measure both hypercoagulability and hypo- 
coagulability, and should be suitable for 
visual inspection in graphs or curves so that 
the changing kinetics of coagulation can be 
followed during the course of the disease and 
its therapy. Although the thrombin genera- 
tion test and the thrombelastogram measure 
both overlapping but different clotting 
-VON K A U L L A  ET A L  - 
fill all three criteria. Since the thrombin 
time measures both heparin and heparin-like 
thrombin inhibitors, it adds a potentially 
useful additional dimension. None of the 
three examinations requires plasma dilution, 
so that the natural relation between factors 
inhibiting and promoting coagulation is not 
disrupted. Other tests can be considered as 
ancillary and used for the answer of specific 
detailed questions. 
Summary 
Blood coagulation was studied in patients 
with chronic renal failure in order to char- 
acterize the clotting deficiency in such pa- 
tients and to assess the effects of therapy. 
The most comlnon abnormalities of uremia 
seemed attributable to platelet dysfunction 
with consequent reduction of the conversion 
of prothrombin to thrombin; reduced 
thrombin generation and shortened serum 
prothrombin times resulted. This defect was 
apparently not usually caused by thrombo- 
cytopenia. Rather, it appeared that some 
substance may have been present in azo- 
temic plasma which inhibited platelet func- 
tion. In  vitro addition of substances such 
as brain lipid or  fresh-f rozen platelet-rich 
plasma corrected the coagulation deficiency. 
Systemic therapy with fresh-frozen platelet- 
rich plasilla seemed of some benefit. 
Hemodialysis was shown to improve 
clotting in several cases but this effect was 
inconstant and transient. I n  contrast, renal 
homotransplantation rapidly restored good 
coagulation in direct parallel with and for 
as long as the persistence of good renal 
function. The correction usually exceeded 
normal, leading to a state of hypercoagula- 
bility primarily from the first to third post- 
operative weeks; this transient finding could 
help explain the heightened incidence of 
pulmonary embolization during this time. 
This study was supported by grant H E  5538 and 5 T1 
5638 from the National Heart Institute, US Public Health 
Service; and AM 06283, AM 06344, H E  07735, AM 07772, 
A1 04152, FR 00061, and FR 00069 from the U S  Public 
Health service. 
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Histologic Changes in Clinically 
Normal Breasts at Postmortem Examination 
LOREN J. HUMPHREY, MD, BUFFALO, NY, AND MARTIN SWERDLOW, MD, CHICAGO 
I N  A PREVIOUS publication l we re- 
ported that severe epithelial hyperplasia of 
the large ducts was found in 69% of breasts 
removed for carcinoma and in only 16% of 
breast tissue diagnosed as "fibrocystic dis- 
ease." Having defined and usedl our own 
criteria for the micropathological character- 
ization of benign breast changes associated 
with carcinoma of the breast and "fibro- 
cystic disease" of the breast, it became 
necessary to ascertain the frequency of these 
changes in clinically normal breasts. 
This study was undertaken to determine 
the breast changes in 100 consecutive au- 
topsies of women 20 years of age and older 
with clinically normal breasts. 
Methods and Results 
This histologic study, as our previous 
study, evaluated severe epithelial hyperplasia 
of the large ducts, the small ducts, and the 
acini. The presence or absence of fibrosis, 
sclerosing adenosis, papillomas, apocrine 
changes, and cysts was noted. The detailed 
tions in women 20 years of age and older 
with clinically normal breasts were reviewed. 
Slides of breast tissue from these autopsies 
were evaluated. I t  can be seen from the 
Table that in only 6% of these cases could 
we find severe epithelial hyperplasia of the 
large ducts. Severe epithelial hyperplasia of 
the small ducts and epithelial hyperplasia 
of acini was found in 17% and 2193, respec- 
tively. For comparison with the benign 
breast changes associated with fibrocystic 
disease and carcinolna of the breast see col- 
umns 2 and 3 of the Table. The results of 
our studies of benign breast changes asso- 
ciated with fibrocystic disease and carcinoma 
of the breast were published previously and 
are included for illustrative purposes. 
Benign bread changes i n  clinically normal breasts 
from 100 colzsecutive autopsies, in breasts 
diagnosed as fibrocystic disease * and in 
breasts removed for carcinoma* 
Fibrocystio 
100 Autopsies, Disease, Carcinoma, 
Histology 4, Change % Change '% Change .'- 
criteria for ~i~icroscopic changes was de- Largcducts 6 t  16 t 69 t 
scribed in a previous p~blicat ion.~ Small ducts 17 58 39 Acini 21 74 23 
Beginning with Jan 1, 1955, we reviewed Fibrosis 64 92 88 
Sclerosing adenosis 23 28 19 the autopsy records of the pathology de- papillomas 2 22 15 
partrnent of University of Illinois Research ApocrinechangeS 28 50 47 
Cysts 36 67 65 
and Educational Hospital, Chicago. Reports -- - -- 
of 100 consecutive postmortem exainina- Tota1 number patients loo 61 156 
Submitted for publication Nov 1, 1965. 
F~~~ the departments pathology and surgery, ~ ~ i ~ ~ ~ .  * Columns 2 and 3 which were previously reported1 are in- 
sity of Illinois College of Medicine, Chicago. cluded for comparison with results in column 1. 
Rer~rint requests to 462 Crider St. Buffalo. NY 14215 (Dr. t Figures represent percent of patients i n  each group with 
histologic changes. 
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